As part of her ongoing research in oncology at UNC, Dr. Demore's article "Inhibition of SFRP2 Found to Inhibit Growth of Triple-negative Breast Tumors." will be published in the May 1st edition of the American Society of Clinical Oncology's bi-monthly publication, the ASCO Post.
The ASCO Post is a newspaper-style publication published by Harborside Press under a license arrangement with the American Society of Clinical Oncology. The publication is circulated to approximately 27,000 oncologists and other cancer specialists, including all ASCO members within the United States.
To view Dr. Demore's article and the latest realease of the ASCO Post, visit their website.